✦ LIBER ✦

4-Aminopyridine in multiple sclerosis

✍ Scribed by C. H. Polman; H. A. M. van Diemen; M. M. M. M. van Dongen; J. C. Koetsier; A. C. van Loenen; H. K. van Walbeek

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

4-Aminopyridine improves clinical signs

✍ Dr. D. Stefoski; F. A. Davis; M. Faut; C. L. Schauf 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 849 KB

Orally administered 4-aminopyridine impr

✍ MD Floyd A. Davis; MD Dusan Stefoski; Jean Rush 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 886 KB

Mechanism of action of 4-aminopyridine i

✍ Floyd A. Davis; Dusan Stefoski; Fred N. Quandt 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 124 KB 👁 2 views

The current status of studies of aminopy

✍ Dr Christopher T. Bever Jr 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 387 KB 👁 2 views

Oral session 16—Multiple sclerosis (4)

📂 Article 📅 1995 🏛 Springer 🌐 English ⚖ 322 KB

The effect of 4-aminopyridine on clinica

✍ Harriët A. M. van Diemen; Dr. Chris H. Polman; Theo M. M. M. van Dongen; Arie C. 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 806 KB